Results 121 to 130 of about 1,975 (157)

Distinct genetic variants from the whole-exome sequencing of syndromic anorectal malformations: A cross-sectional study. [PDF]

iScience
Suseelan V, Krishna A A, Zawar A, Prabhu PS, Bhatta P, Paliwal A, Mathur P, Medicherla KM, Polipalli SK, Suravajhala P.   +9 more
europepmc   +1 more source

Inactivation of ornithine aminotransferase by (1<i>R</i>,4<i>S</i>)-4-Amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid via a stable quinonoid intermediate. [PDF]

Med Chem Res
Kang KM, Vargas AL, Zhu W, Sokolenko I, Liu D, Silverman RB.   +5 more
europepmc   +1 more source

Revisiting the INSPIRE trial: antibody profiling reveals high prevalence of occult autoimmunity. [PDF]

Respir Res
Glassberg MK, Burg C, Pereira-Simon S, Trzaskoma B, Harlow L, Biedka S, Elliot S, Zhang Y, VanEvery H, Fertig N, Minden JS, Ascherman DP.   +11 more
europepmc   +1 more source

Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer. [PDF]

Int J Mol Sci
Chen H, Chen Q, Chen J, Mao Y, Duan L, Ye D, Cheng W, Chen J, Gao X, Lin R, Lin W, Zhang M, Qi Y.   +12 more
europepmc   +1 more source

The research advances of crosstalk between cancer-associated fibroblasts and tumor cells using co-culture organoids. [PDF]

Cell Death Dis
Wang M, Ding X, Chen L, Cui Z, Ding Y, Song Y, Li W, Zhang X.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PYCR1, BANF1, and STARD8 Expression in Gastric Carcinoma: A Clinicopathologic, Prognostic, and Immunohistochemical Study

Applied Immunohistochemistry & Molecular Morphology, 2023
Background: It will be important to understand the molecular pathways of gastric cancer (GC) occurrence and progression, thus detecting predictive and prognostic biomarkers of GC.
O. Harb, M. Elfeky, M. Alabiad, Rehab Hemeda, A. Allam, Amr T El Hawary, Mohammed Elbaz, Ahmed L Sharaf, Loay M. Gertallah, A. M. Abdelaziz, A. Shalaby, Mohammed Alorini, A. Yahia, Mohamed Negm   +13 more
semanticscholar   +3 more sources

PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling

Journal of Bioenergetics and Biomembranes, 2021
Pyrroline-5-carboxylate reductase 1 (PYCR1) plays a significant role in the malignant progression of various cancers. However, the role of PYCR1 in bladder cancer has not been well studied. This study was performed to evaluate the potential relevance of PYCR1 in bladder cancer.
Yongjie Sui, Chun Du
exaly   +3 more sources

Successful Reduction of a Dislocated Hip Joint in a Patient With Cutis Laxa From a PYCR1 Mutation

JBJS Case Connector
Case: We report a successful surgical management of a teratologic hip dislocation in a 2.5-year-old girl child with cutis laxa and a positive PYCR1 gene mutation.
O. Samarah, D. H. CHSOrtho, MD S.J Abu Rumman, Marzouki Ibrahim, M. Hamed, Obeidat   +5 more
semanticscholar   +3 more sources

MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer

Biochemical and Biophysical Research Communications, 2021
Prostate cancer, the most common non-cutaneous male cancer, is a public health problem with a third prevalence worldwide. PYCR1 and miR-1207-5p dysregulations were found in cancer progression. Our study aims to reveal the biological role of miR-1207-5p-PYCR1 axis in prostate cancer progression.
Yi Yang, Yi Yang
exaly   +3 more sources